Home
Rahul D. Ballal, Director: Enliven Therapeutics ELVN Sell · Filed 24/03/22
Trade details
- Type
- Insider sale
- Amount
- $254,406.48
- Shares · price
- 13,278 sh · $19.16 a share
- Held after
- 22,341 sh
- Person
- Rahul D. BallalDirector
- Trade date
- 24/03/20
- Filed
- 24/03/22
- Days to filing
- 2 days
Sold 37.3% of holdings
- Share of holding sold
- 37.3%
Enliven Therapeutics trades, last 26 weeks
What else happened in Enliven Therapeutics around then
Filed or reported within 30 days of the trade day · 24/02/19~24/04/19Rahul D. Ballal's recent trades
- Rahul D. Ballal
Sell10b5-1 planAgios Pharmaceuticals
Sell10b5-1 planAgios Pharmaceuticals
AGIO
$433.6K
8,132 sh
$433.6K
Filed 24/11/12
Traded 24/11/07
- Rahul D. Ballal
Sell10b5-1 planAgios Pharmaceuticals
Sell10b5-1 planAgios Pharmaceuticals
AGIO
$288.7K
4,929 sh
$288.7K
Filed 24/11/12
Traded 24/11/08
- Rahul D. Ballal
Sell10b5-1 planAgios Pharmaceuticals
Sell10b5-1 planAgios Pharmaceuticals
AGIO
$204.4K
3,571 sh
$204.4K
Filed 24/11/12
Traded 24/11/08
- Rahul D. Ballal
Sell10b5-1 planAgios Pharmaceuticals
Sell10b5-1 planAgios Pharmaceuticals
AGIO
$101.6K
1,868 sh
$101.6K
Filed 24/11/12
Traded 24/11/07
- Rahul D. Ballal
Sell10b5-1 planAgios Pharmaceuticals
Sell10b5-1 planAgios Pharmaceuticals
AGIO
$88.8K
1,500 sh
$88.8K
Filed 24/11/12
Traded 24/11/08
